Experts in Conversation: Highlights from AAIC 2024 with Sharon A Brangman, Argonde van Harten and Gemma Salvadó | Journey to a New Era for Alzheimer’s Disease
Released On
April 3, 2024
Expires On
November 30, 2025
Media Type
Internet
Completion Time
41 minutes
Specialty
Geriatric Medicine, Neurology, Psychiatry
Topics
Alzheimer's, Dementia
This activity is supported by an educational grant from Lilly.
Credit Available
- Physicians — 0.5 AMA PRA Category 1 Credits™
Target Audience
Global neurologists, geriatricians and geriatric psychiatrists. The program content will be suitable for gerontologists as well as nurse practitioners and physician assistants who are involved in the care of patients with AD.
Program Overview
2024 brought pivotal advances in neurodegenerative biomarkers for early Alzheimer’s detection, insights into amyloid-targeted therapies and patient selection, and new strategies for ARIA risk assessment and management.
Revisit 2024 Conference Highlights for Alzheimer’s Disease. Watch Experts in Conversation: Highlights from AAIC, featuring Sharon A Brangman (USA), Argonde van Harten (The Netherlands) and Gemma Salvadó (Sweden).
This program is part of the larger initiative, Journey to a New Era for Alzheimer’s Disease. Register for free to access news articles, video highlights, accredited expert discussions, concise research summaries, podcasts, and interactive quizzes to test your knowledge: https://new-era-alzheimers-disease.ime.springerhealthcare.com/.
Learning Objectives
After participating in this program, you will be able to:
- Endorse the importance of a proactive and accurate diagnosis of early-stage AD
- Evaluate the rationale and utility of current and emerging biomarkers within the current diagnostic work-up
- Identify which patients would most benefit from amyloid-targeted therapy use through the analysis of the most current data
- Appraise the current understanding around risk factors, detection methods, and management approaches for ARIA
Faculty
Dr Argonde van Harten
Neurologist, Amsterdam UMC, The Netherlands
Argonde van Harten, MD PhD, is a neurologist at the Alzheimer Center Amsterdam, Amsterdam UMC, location VUmc. She has dedicated her scientific career to improving Alzheimer’s disease diagnosis using fluid biomarkers and digital cognitive assessment. Her current research focusses on implementation of fluid biomarkers into clinical practice, both in memory clinics and in primary care. In addition, she is the principal investigator of a project investigating the association between immune age and Alzheimer’s disease. She is a collaborator in several (inter)national research projects, such as the diagnostic accelerator programme of the Davos Alzheimer Collaborative, AD-RIDDLE, PROMINENT, SCIENCe, the ABOARD project and CANTATE. Her clinical work focusses on diagnosing and treating all types of dementia.
Amsterdam, The Netherlands
Professor Sharon A Brangman
Professor and Chair of the Department of Geriatrics, SUNY Upstate Medical University, NY, USA.
Sharon A Brangman is a SUNY Distinguished Service Professor and Chair of the Department of Geriatrics at SUNY Upstate Medical University. Prior to this appointment, she had been the Division Chief of Geriatrics for 20 years. She is the Founding Director of the Geriatric Medicine Fellowship Program and served in this position for over thirty years. Dr. Brangman is director of the Center of Excellence for Alzheimer’s Disease, is also Medical Director of the Transitional Care Unit on the Upstate Community Campus, was Medical Director of Greenpoint/The Hearth Senior Living Communities in Syracuse, New York for 17 years. Dr Brangman has received many honors, including Best Doctors of Northeast Region, the Chancellor’s Award for Faculty Service and Hartford Geriatrics Leadership Scholars Award. Dr Brangman was a member of the Board of Directors of the American Geriatrics Society for ten years and completed terms as President and Chair of the Board. She also served as Chair of the Board of the Association of Geriatric Academic Program Directors, after completing a term as its President.
New York, USA
Dr Gemma Salvadó
Dr Gemma Salvadó
Associate Researcher, Lund University, Sweden
Gemma Salvadó is currently an associate researcher at Lund University (Sweden). She was awarded the prestigious Marie Skłodowska-Curie post-doctoral fellowship for her outstanding research. Dr Salvadó completed her PhD at the Barcelonaβeta Brain Research Center (Spain), where she focused on understanding the preclinical stages of Alzheimer’s disease through the use of neuroimaging and fluid biomarkers. Her current work involves studying plasma and cerebrospinal fluid biomarkers to gain insights into the disease progress.
Lund, Sweden
Accreditation Statement
Credits Available
Completing one Expert in Conversation activity will earn you 0.5AMA PRA Category 1 Credits™. The activity for CTAD is separated into 2 videos and you will need to watch both to earn 0.5. You can earn a total of 1.5 credits for all four activities.
In support of improving patient care, this activity has been planned and implemented by Postgraduate Institute for Medicine and Springer Healthcare IME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
As part of the planning committee Rebecca Cox and Jules Morgan have no interests to disclose.
Disclosures of Conflicts of Interest
Professor Sharon A Brangman
Disclosures: A Brangman has received honoraria and or consultation fees from Eisai and Genentech/Roche. All relevant financial relationships have been mitigated.
Dr Argonde van Harten
Disclosures: Argonde van Harten has received grants and/or research support from Alzheimer Nederland ZonMW ADDF. All relevant financial relationships have been mitigated.
Dr Gemma Salvadó
Gemma Salvadó has no disclosures. All relevant financial relationships have been mitigated.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Your certificate will be made available for immediate download.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Springer Healthcare IME requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CE questions, please contact: [email protected].